ArticleiGIE : innovation, investigation and insights2023
Exposed versus nonexposed endoscopic full-thickness resection for duodenal subepithelial lesions: a tertiary care center experience (with videos).
Article in iGIE : innovation, investigation and insights, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07142902 (Gastroduodenal Full Thickness Resection Device Registry - gdFTRD® Registry), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Gastroduodenal Full Thickness Resection Device Registry - gdFTRD® Registry
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Endoscopic full-thickness resection (EFTR) has been shown to be effective in selected lesions located in the stomach and colorectum. Data regarding the feasibility, safety, and efficacy of EFTR in the duodenum are limited. In this study, we aimed to evaluate the feasibility and safety of exposed and nonexposed EFTR in patients with large (≥10 mm) duodenal subepithelial lesions. Methods: Data of all patients who underwent EFTR for duodenal subepithelial lesions with exposed and nonexposed (device-assisted) techniques were analyzed, retrospectively. The primary outcome of the study was technical success of EFTR in the duodenum. Secondary outcomes were adverse events, R0 resection, and recurrence at follow-up. Results: Twenty patients with duodenal subepithelial lesions (mean size, 14.2 ± 3.6 mm) underwent EFTR during the study period. Exposed and nonexposed EFTRs were performed in 11 and 9 patients, respectively. The mean procedure duration was 70.3 ± 46.5 minutes. Technical success with exposed and nonexposed techniques was 100% and 75%, respectively. Histologically complete resection (R0) was achieved in 15 patients (75%). Moderate and severe adverse events were recorded in 3 patients, including a leak in 2 patients and partial obstruction of the lumen in 1 patient. Conclusions: EFTR is feasible in large duodenal subepithelial lesions with a reasonable safety profile. EFTR enables complete resection in most duodenal subepithelial lesions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.